Skip to main content
FibroGen, Inc. (LON:0IL8)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.3172
+0.0045 (1.43%)
At close: Apr 24, 2025

FibroGen Revenue

In the year 2024, FibroGen had annual revenue of $29.62M USD, down -36.71%. FibroGen had revenue of $3.14M in the quarter ending December 31, 2024.

Revenue
$29.62M
Revenue Growth
-36.71%
P/S Ratio
1.03
Revenue / Employee
$131.65K
Employees
225
Market Cap
24.28M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings

FibroGen News

More News